24/12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

24/12/2024

Dec 24, 2024, 17:32 | Blog
Three-Year Overall Survival with Nivolumab + Relatlimab rela-nivo in Advanced Melanoma
Marco Donia shared on LinkedIn: "Three-Year Overall Survival with Nivolumab + Relatlimab (rela-nivo) in Advanced…
Dec 24, 2024, 17:29 | Blog
VCU Massey Comprehensive Cancer Center - Current obstacles in achieving equitable care for patients with cancer
VCU Massey Comprehensive Cancer Center shared on X: "In March, Dr. Rob Winn spoke about…
Dec 24, 2024, 17:24 | Blog
Anirban Maitra: The ability to run mass spectrometry metabolomics and spatial transcriptomics on the same cancer tissue
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Dec 24, 2024, 17:10 | Societies
2024 ASCO Election Results
ASCO released the outcome of its 2024 elections for the President of the 2026-2027 term,…
Dec 24, 2024, 16:51 | Blog
New Officer and Directors to Join Society of Surgical Oncology Board on 2025-2028 Term
Society of Surgical Oncology shared on X: "The Society of Surgical Oncology (SSO) is pleased to…
Dec 24, 2024, 16:42 | Blog
Relapsed head and neck squamous cell carcinoma unrelated to HPV infection
NCI Center for Cancer Research shared on LinkedIn: "NEW FINDING: Relapsed head and neck squamous cell…
Dec 24, 2024, 16:39 | Blog
The V Foundation's December Star award goes to Paul Chrisman
The V Foundation shared on LinkedIn: "We're excited to share that our December STAR award goes…
Dec 24, 2024, 16:33 | Blog
NCI Division of Cancer Prevention - 6 valid screening tools for malnutrition risk identification in outpatient oncology settings
NCI Division of Cancer Prevention shared on LinkedIn; "New publication: Research shows that between 25% to…
Dec 24, 2024, 16:17 | Blog
Vivek Subbiah: The latest and greatest in cancer research in 2024
Vivek Subbiah shared on LinkedIn: "Published online Live now on FOXNEWS - So excited to share…
Dec 24, 2024, 16:14 | Blog
Karen Knudsen: Only 1/3 of patients receive 1L treatment intensification with an AR pathway inhibitor and/or docetaxel
Karen Knudsen shared on LinkedIn: "Prostate cancer remains the second leading cause of cancer-related deaths in…
All: 77 Posts: 21 - 30
Special Coverage